BZYR (Burzynski Research Institute) Tariff Resilience Score: 7/10 (As of Jul. 05, 2026)


What is Burzynski Research Institute Tariff Resilience Score?

Burzynski Research Institute BZYR -46.31% Tariff Resilience Score is 7 as of Jul. 05, 2026. Among 1,373 Biotechnology companies, Burzynski Research Institute ranks better than 90.39% on this metric.

Burzynski Research Institute has the Tariff Resilience Score of 7, which implies that the company might have Highly Resilient.

Burzynski Research Institute has Research-focused with limited manufacturing and international trade exposure. Tariffs have minimal direct impact on operations.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Burzynski Research Institute might have Highly Resilient.


Burzynski Research Institute  (OTCPK:BZYR) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Burzynski Research Institute Tariff Resilience Score Related Terms


BZYR vs AGTX, EMMA, ATXI: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Burzynski Research Institute's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Burzynski Research Institute Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Burzynski Research Institute's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 7 mean?
Burzynski Research Institute (BZYR) has a Tariff Resilience Score of 7 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Burzynski Research Institute ranks #132 out of 1373 companies in the Biotechnology industry, placing it in the top 9.6%.
Is Burzynski Research Institute's Tariff Resilience Score too high?
Burzynski Research Institute's current Tariff Resilience Score is 7. The Biotechnology industry median Tariff Resilience Score is 4.00. Burzynski Research Institute's value of 7 is 75% above this industry median. Based on the distribution chart, Burzynski Research Institute ranks #132 out of 1373 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers.
How does Burzynski Research Institute's Tariff Resilience Score compare to AGTX and EMMA?
According to the Biotechnology industry distribution chart, Burzynski Research Institute ranks #132 out of 1373 companies for Tariff Resilience Score. This places Burzynski Research Institute in the top 10% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Burzynski Research Institute's value of 7 is 75% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,373 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Burzynski Research Institute's current Tariff Resilience Score of 7 is 75% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Burzynski Research Institute's current Tariff Resilience Score is 7. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burzynski Research Institute stock overvalued right now?
Burzynski Research Institute (BZYR) has a current Tariff Resilience Score of 7. The current Tariff Resilience Score is 7 and 75% above the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Burzynski Research Institute (BZYR), the current Tariff Resilience Score is 7 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Burzynski Research Institute Business Description

Address 9432 Katy Freeway, Houston, TX, USA, 77055
Burzynski Research Institute Inc operates as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.